Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cbiz (CBZ) Cash & Equivalents (2016 - 2025)

Cbiz (CBZ) has disclosed Cash & Equivalents for 16 consecutive years, with $18.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 32.29% year-over-year to $18.3 million, compared with a TTM value of $18.3 million through Dec 2025, up 32.29%, and an annual FY2025 reading of $18.3 million, up 32.29% over the prior year.
  • Cash & Equivalents was $18.3 million for Q4 2025 at Cbiz, up from $17.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $39.8 million in Q2 2025 and bottomed at $558000.0 in Q1 2022.
  • Average Cash & Equivalents over 5 years is $7.2 million, with a median of $3.8 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents crashed 96.88% in 2021, then soared 3429.88% in 2025.
  • Year by year, Cash & Equivalents stood at $2.0 million in 2021, then surged by 135.2% to $4.7 million in 2022, then soared by 72.24% to $8.1 million in 2023, then skyrocketed by 70.9% to $13.8 million in 2024, then skyrocketed by 32.29% to $18.3 million in 2025.
  • Business Quant data shows Cash & Equivalents for CBZ at $18.3 million in Q4 2025, $17.0 million in Q3 2025, and $39.8 million in Q2 2025.